Recent

% | $
Quotes you view appear here for quick access.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

  • maxdad01 maxdad01 Apr 25, 2013 10:21 AM Flag

    150 NEW REPS--Annualized EBITDA based contributions to EPS

    150 NEW REPS
    Average revenue per rep is more than $1.5 MILLION
    = $225 MILLION INCREMENTAL REVENUE
    $225 Million X 40% (conservative) NET MARGIN (EBITDA)=$100 MILLION EBITDA CONTRIBUTION
    40% Composite EBITDA Interest, Tax and Depreciation charges (NO INTEREST---DEBT FREE)=
    $60 MILLION CONTRIBUTION TO EPS...OR APPROX. $1.00 EPS

    ADD $1.00 TO THE NO GROWTH ESTIMATE (Ridiculous on the face of it) OF $5.36 AND YOU'RE AT $6.36 EPS. ONE MORE ADDITION...ORGANIC GROWTH FROM PRIOR REP FORCE=40 CENTS PER SHARE AND YOU'RE AT $6.76 EPS...Just 3 cents shy of my $6.79 BOTTOM EPS UP FORECAST FOR 2013.

    NOTE---THIS ESTIMATE DOES NOT INCLUDE EITHER ADDITIONAL CONTRIBUTIONS FROM INDICATIONS CURRENTLY UNDER EXAMINATION (OVER 50 CURRENT TRIALS) NOR DOES IT INCLUDE EITHER NEPHROLOGY NOR RHEUMATOLOGY MOVING ABOVE EXISTING GROWTH TREND OTHER THAN NEW REP CONTRIBUTIONS...I.E., ORGANIC GROWTH!!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
QCOR
93.600.00(0.00%)Aug 14 4:00 PMEDT